W Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
W Advisors's BMY Position: Q3 2026 in Review
W Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.26% in Q3 2026, buying an estimated $3.1K and bringing the position to 18,568 shares worth $1.16M. The position accounts for 0.51% of the portfolio, ranked #45.
W Advisors first reported a position in BMY in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.87M in Q2 2022. 2,284 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- W Advisors held 18,568 shares of Bristol-Myers Squibb worth $1.16M as of Q3 2026.
- W Advisors bought 49 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.1K.
- Bristol-Myers Squibb made up 0.51% of W Advisors's portfolio in Q3 2026, its #45 holding.
- W Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 20 quarters since.
- W Advisors's Bristol-Myers Squibb position peaked at $1.87M in Q2 2022.
- 2,284 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on W Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.